Cargando…
Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy
BACKGROUND: Allergic reactions have been reported with mRNA vaccines for COVID-19 prevention. Patients perceived to be at higher risk for a reaction may be referred to an allergist, although evaluation strategies may differ between allergists. OBJECTIVE: Our aim was to determine outcomes of COVID-19...
Autores principales: | Khokhar, Dilawar, O’Shea, Kelly M., Akin, Cem, Baldwin, James L., Benjamin, Mariel R., Ravikumar, Rajan, Hosler, Mirie, McMorris, Marc S., Sanders, Georgiana M., Troost, Jonathan P., Baptist, Alan P., Oberdoerster, Deborah T., Kovalszki, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374488/ https://www.ncbi.nlm.nih.gov/pubmed/36090592 http://dx.doi.org/10.1016/j.jacig.2022.05.012 |
Ejemplares similares
-
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021) -
The Association of BCG Vaccination with Atopy and Asthma in Adults
por: Park, Sung Soo, et al.
Publicado: (2015) -
Can COVID-19 vaccinations cause chronic urticaria?
por: Chu, Stacey, et al.
Publicado: (2023) -
Injectable Excipients as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019) -
Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)